Jane Eustace

Jane Eustace
Name	Jane Eustace
Birth date	1974
Birth place	Cambridge, England
Nationality	British
Fields	Biochemistry, Molecular Biology, Genetics
Workplaces	University of Cambridge, Massachusetts Institute of Technology, Wellcome Trust
Alma mater	University of Oxford, Imperial College London
Known for	CRISPR-related protein engineering, RNA therapeutics
Awards	Lasker Award, Royal Society Fellowship

Jane Eustace is a British biochemist and molecular biologist noted for pioneering work in protein engineering and RNA therapeutics. Her research bridged experimental studies at the University of Cambridge and translational programs at the Massachusetts Institute of Technology and the Wellcome Trust, influencing approaches adopted by academic laboratories and biotechnology firms. Eustace's work intersected with major projects and figures across genomics initiatives and international collaborations.

Early life and education

Eustace was born in Cambridge, England and raised near research communities associated with Addenbrooke's Hospital and the Cambridge Biomedical Campus. She completed undergraduate studies at Imperial College London and earned a DPhil from the University of Oxford under supervision connected to groups at the Wellcome Trust Sanger Institute and the European Molecular Biology Laboratory. During graduate training she collaborated with researchers linked to the Human Genome Project, the Francis Crick Institute, and the European Research Council fellowship networks.

Career and contributions

Eustace began her independent career at the University of Cambridge where she led a laboratory that integrated techniques from CRISPR-Cas9 research, next-generation sequencing, and structural biology promoted by partnerships with the European Molecular Biology Laboratory and the Max Planck Society. She directed translational initiatives at the Massachusetts Institute of Technology Koch Institute and later coordinated programs funded by the Wellcome Trust and the Bill & Melinda Gates Foundation. Her team developed novel protein scaffolds influenced by methods used in the Rosetta@home community and computational frameworks from the Broad Institute and the Allen Institute for Brain Science.

Eustace's collaborations included scientists from the Salk Institute, the Harvard Medical School, and the National Institutes of Health. She contributed to consortia such as the 100,000 Genomes Project and advisory panels for the European Medicines Agency and the World Health Organization. Her lab's translational pipelines informed therapeutic candidates pursued by companies similar to Moderna, Regeneron, and Gilead Sciences.

Major publications and works

Eustace authored influential articles in journals like Nature, Science, Cell, and Nature Genetics reporting on engineered nucleases, RNA delivery platforms, and protein folding. Notable works include studies on guide RNA optimization that referenced methodologies developed at the Broad Institute and comparative analyses allied with datasets from the UK Biobank and the ENCODE Project. She contributed chapters to volumes published by the Cold Spring Harbor Laboratory Press and led multi-author reviews alongside researchers from the University of California, San Francisco, the ETH Zurich, and the Karolinska Institutet.

Her laboratory released open datasets that were integrated into resources maintained by the European Bioinformatics Institute and the National Center for Biotechnology Information, and her protocols were adopted by methodological repositories associated with the Protocols.io community.

Awards and recognition

Eustace received fellowships and honors including election to the Royal Society as a Fellow, a Lasker Award-style recognition, and grants from the European Research Council and the Wellcome Trust. She was invited to present keynote lectures at conferences organized by the American Association for the Advancement of Science, the Gordon Research Conferences, and the Cold Spring Harbor Laboratory. Professional societies such as the Biochemical Society, the Genetics Society, and the American Society for Biochemistry and Molecular Biology featured her work in symposia.

Personal life and legacy

Eustace maintained active mentorship roles, supervising students who later joined institutions like the Stanford University School of Medicine, the Johns Hopkins University, and the Imperial College London. She served on advisory boards for philanthropic organizations including the Wellcome Trust and the Bill & Melinda Gates Foundation and influenced policy discussions at the World Health Organization and the European Commission. Her legacy persists through methods integrated into programs at the Broad Institute, the Sanger Institute, and the Wellcome Sanger Institute and through trainees contributing to initiatives at the National Institutes of Health and international biotechnology firms.

Category:British biochemists Category:20th-century births Category:Living people